Increased HER2 expression and activity, demonstrated by increased downstream AKT activation, is also seen in feline mammary carcinomas, though there is variation among studies with regard to the rate of HER2 expression and methodologies used [79,84,86,87,88,89,90]. The gene discussed is ERBB2; the disease is breast carcinoma.